Tartrate-resistant acid phosphatase 5a in sarcoidosis: further evidence for a novel macrophage biomarker in chronic inflammation.

J Formos Med Assoc 2014 Jun 1;113(6):364-70. Epub 2012 Sep 1.

Division of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC; Division of Hematology and Oncology, Department of Medicine, Taipei Medical University, Shuang Ho Hospital, Taipei, Taiwan, ROC. Electronic address:

Background/purpose: Tartrate-resistant acid phosphatase (TRACP) 5a is expressed strongly in inflammatory macrophages (MΦ). Serum TRACP5a is elevated in rheumatoid arthritis patients with extra-articular manifestations of rheumatoid nodules, in a percentage of patients with end-stage chronic kidney disease, and may be a risk marker for acute myocardial infarction. This proof-of-concept study was undertaken in patients with sarcoidosis to further substantiate our hypothesis that TRACP5a protein is a biomarker for macrophages in other chronic inflammatory diseases.

Methods: Immunohistochemical staining for TRACP5a and CD68 was performed in tissues of 19 patients with sarcoidosis. We also measured circulating TRACP5a protein and other inflammation biomarkers including interkeukin-6, angiotensin-converting enzyme, and C-reactive protein in 13 patients. Twenty healthy age-matched nonsmoking individuals were used as the reference group.

Results: All sarcoidosis tissues showed strong staining for TRACP5a and CD68 in the non-caseating granulomatous lesions and localized specifically to MΦ, multinucleate giant cells, and epithelioid MΦ. Serum TRACP5a protein was elevated significantly in active sarcoidosis patients compared with the control group, and levels fluctuated with disease activity in one patient studied longitudinally.

Conclusion: TRACP5a protein is expressed abundantly in the granulomatous tissues and may be elevated in a significant proportion of sarcoidosis patients. These findings further support our hypothesis that serum TRACP5a is derived from systemic inflammatory MΦ and thereby may be a biomarker of inflammation for sarcoidosis and also reflect its disease activity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfma.2012.07.033DOI Listing
June 2014
5 Reads

Publication Analysis

Top Keywords

tracp5a protein
16
serum tracp5a
12
sarcoidosis patients
8
mΦ serum
8
disease activity
8
tracp5a cd68
8
patients sarcoidosis
8
staining tracp5a
8
tracp5a
8
acid phosphatase
8
tartrate-resistant acid
8
patients
7
sarcoidosis
7
protein
5
tissues patients
4
immunohistochemical staining
4
localized mΦ
4
lesions localized
4
diseasesmethods immunohistochemical
4
abundantly granulomatous
4

Similar Publications